Katelyn Byrne, Ph.D., is senior author of a new OHSU study in the journal Immunity that identifies a potential path to making immunotherapy effective against pancreatic cancer. (IMAGE)

Oregon Health & Science University

Katelyn Byrne, Ph.D., is senior author of a new OHSU study in the journal Immunity that identifies a potential path to making immunotherapy effective against pancreatic cancer.

Caption

Photo of pancreatic cancer cell under a microscope

Credit

OHSU/Christine Torres Hicks

Usage Restrictions

For use with story

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.